🔗 Share this article

An underground market for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Experimental Treatment Gaining Popularity Online

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Viewers are encouraged to message these profiles privately for source information, while also receiving promotional offers.

Thriving Commerce on Social Networks

Separately, a flourishing market exists on messaging services, where groups with thousands of participants share comparison images, injection guides and claims of next-day UK delivery. Sellers market the drug there before directing buyers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and chemists have warned that the distribution of what is still an unapproved drug in the UK is worrisome and could result in users injecting substances of uncertain source.

Several professionals stated the popularity for retatrutide could be connected to the increasing price of approved slimming products such as Mounjaro.

Regulatory Position and Enforcement

Marketing retatrutide on social media or messaging apps is illegal in the UK, as it is an unapproved medication that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate pharmaceutical, advertising, and customer laws, potentially leading to penalties, legal action or prison.

Service Response and Material Elimination

Based on the social media company, the platform has removed violative content and prohibited related keywords and search suggestions. The organization stated it was dedicated to keeping the service secure and allocating resources in enhancing compliance measures.

Online Marketplace Activities

Research also found communities with up to nine thousand members selling retatrutide using Telegram's integrated discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays channels with numerous of users, populated with photos of slimming results, positive testimonials and detailed instructions for preparing or injecting at residence.

Within moments of joining one group, a seller posted WhatsApp details, where most transactions occur. The seller sent an guidebook and promised delivery within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about weight, medical conditions or past usage.

Product Details and Costs

Inside these groups, posts display dark colored parcels with postal service stickers, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at home with sterile water, or ready-to-use injectors typically sold at £160 for 20 milligrams. When questioned how long a injector should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Service Oversight and Security Measures

A spokesperson for the messaging service said it regularly moderated harmful material on its service including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering substances they cannot confirm. Even if the science behind this drug is sound, these digital versions may not include what they advertise,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the increase in interest to recent cost increases for approved weight-loss drugs such as Mounjaro. “With costs rising, individuals are turning to online platforms. But fake treatments are highly risky. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.

Her staff has previously encountered individuals injured by self-injection from unverified sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is taking chances with your health,” stated Wyllie. “These substances could be impure or improperly measured.”

Producer Statement

A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet approved … may expose patients to potentially significant health risks”.